CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Cytiva BioProcess R&D AB v. JSR Corporation

1:21-cv-00310

Overview

Case Number 1:21-cv-00310
Filing Date 2021-02-26
Status Terminated
Termination Date 2025-03-18
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

JSR Life Sciences, LLC Operating Company

Represented By

6 Attorneys Listed

Krystina L. Ho

Email: krystinaho@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Isaac S. Ashkenazi

Email: isaacashkenazi@paulhastings.com

Hiroyuki Hagiwara

Email: hiroyukihagiwara@paulhastings.com

Carl J. Minniti , III

Email: carlminniti@paulhastings.com

Eric W. Dittmann

Email: ericdittmann@paulhastings.com

JSR Micro NV NPE (Individual / Inventor)

Represented By

6 Attorneys Listed

Krystina L. Ho

Email: krystinaho@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Isaac S. Ashkenazi

Email: isaacashkenazi@paulhastings.com

Hiroyuki Hagiwara

Email: hiroyukihagiwara@paulhastings.com

Carl J. Minniti , III

Email: carlminniti@paulhastings.com

Eric W. Dittmann

Email: ericdittmann@paulhastings.com

JSR Corporation NPE (Individual / Inventor)

Represented By

6 Attorneys Listed

Krystina L. Ho

Email: krystinaho@paulhastings.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Isaac S. Ashkenazi

Email: isaacashkenazi@paulhastings.com

Hiroyuki Hagiwara

Email: hiroyukihagiwara@paulhastings.com

Carl J. Minniti , III

Email: carlminniti@paulhastings.com

Eric W. Dittmann

Email: ericdittmann@paulhastings.com

Plaintiff

Cytiva Sweden AB NPE (Individual / Inventor)

Represented By

7 Attorneys Listed

Andrew Hoffman

Email: ahoffman@wc.com

Sarahi Uribe

Email: suribe@wc.com

Omid G. Banuelos

Email: obanuelos@wc.com

David M. Krinsky

Email: dkrinsky@wc.com

David I. Berl

Email: dberl@wc.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Cytiva BioProcess R&D AB Operating Company

Represented By

7 Attorneys Listed

Andrew Hoffman

Email: ahoffman@wc.com

Sarahi Uribe

Email: suribe@wc.com

Omid G. Banuelos

Email: obanuelos@wc.com

David M. Krinsky

Email: dkrinsky@wc.com

David I. Berl

Email: dberl@wc.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 6 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (6 found):
PTAB: 6
USPTO PTAB Trial 2021-10-12
IPR2022-00045

JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.

U.S. Continuation Sibling (10875007)
Status: Final Written Decision
USPTO PTAB Trial 2021-10-12
IPR2022-00044

JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.

U.S. Continuation Sibling (10343142)
Status: Final Written Decision
USPTO PTAB Trial 2021-10-12
IPR2022-00043

JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2021-10-12
IPR2022-00042

JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.

U.S. Continuation Sibling (10875007)
Status: Final Written Decision
USPTO PTAB Trial 2021-10-12
IPR2022-00041

JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.

U.S. Continuation Sibling (10343142)
Status: Final Written Decision
USPTO PTAB Trial 2021-10-12
IPR2022-00036

JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.

Asserted Patent
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10213765
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
Filed: 2017-05-23
Issued: 2019-02-26
Active (10.5 yrs remaining)
Expires: 2037-05-23
US10343142
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
Filed: 2018-11-13
Issued: 2019-07-09
Active (12.0 yrs remaining)
Expires: 2038-11-13
US10875007
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
Filed: 2019-06-17
Issued: 2020-12-29
Active (12.6 yrs remaining)
Expires: 2039-06-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

22

Dispositive

0

Granted

0

Denied

0

Pending / Review

13

Motions by Category

Claim Construction / Markman Filing 3 Procedural / Extension Motion 19

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 78 Stipulation and Proposed Order to Extend Time to submit letters to Court in advance of status conference (*Reset deadlines: Opening Letter due...
Entry #— • 2023-07-31
Procedural / Extension Motion Pending / Under Review
STIPULATION and Propose Order to Extend Time to submit letters to Court in advance of status conference, by Cytiva BioProcess R&D AB, Cytiva Sweden AB. (Joyce, ...
Entry #78 • 2023-07-28 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION and Proposed Order to Extend Time Regarding Joint Status Report to be filed by July 19, 2023 - filed by Cytiva BioProcess R&D AB, Cytiva Sweden AB. ...
Entry #73 • 2023-06-15 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 73 STIPULATION and Proposed Order to Extend Time Regarding Joint Status Report to be filed by July 19, 2023. Signed by Judge Richard G. Andrews o...
Entry #— • 2023-06-15
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME (1) for the substantial completion of document production and (2) to submit a joint status report pursuant to the Court's instruction...
Entry #60 • 2022-04-18 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 60 STIPULATION and Proposed Order to Extend Time for the substantial completion of document production and to submit a joint status report to May...
Entry #— • 2022-04-18

Docket Entries

(162 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against JSR Corporation, JSR Life Sciences, LLC, JSR Micro NV - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3550991.) - filed by Cytiva Sweden AB, Cytiva BioProcess R&D AB. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(nmg) (Entered: 03/01/2021)

Entry #1 • 2021-02-26
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 03/01/2021)

Entry #2 • 2021-02-26
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,213,765; 10,343,142; 10,875,007. (nmg) (Entered: 03/01/2021)

Entry #3 • 2021-02-26
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Danaher Corporation for Cytiva BioProcess R&D AB, Cytiva Sweden AB filed by Cytiva BioProcess R&D AB, Cytiva Sweden AB. (nmg) (Entered: 03/01/2021)

Entry #4 • 2021-02-26
1

Summonses Issued (please complete the top portion of the form and print out for use/service). (Attachments: # 1 Summons, # 2 Summons)(nmg) (Entered: 03/01/2021)

Entry #5 • 2021-02-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc